Stefan Tarnawsky, M.D.; Ph.D. is a Hematology/Oncology fellow and junior physician scientist at the Washington University School of Medicine in Saint Louis, MO. His research focus is understanding the origin of myeloid blood cancers. His graduate work at Indiana University with Dr. Merv Yoder and Dr. Rebecca Chan focused on the prenatal origin of childhood blood cancers. This work led to a F30 award from the NHLBI and three first-author research publications, including one in the Journal of Clinical Investigations. Currently, under the mentorship of Dr. Matt Walter, M.D., Stefan studies how splicing factor gene mutations dysregulate blood cell growth. He thereby aims to identify novel therapies for the ~50% of myelodysplastic syndrome patients and ~20% of acute myeloid leukemia patients that have these mutations. His career goal is to continue this research focus as an independent investigator studying and treating blood cancer patients at an academic medical center.

Stefan Tarnawsky MD, PhD
Washington University in St. Louis
St. Louis, Missouri
United States
Project Title
The Role of TP53 in Mutant U2AF1 Myelodysplastic Syndromes
Program
Career Development Program